Your browser doesn't support javascript.
loading
Safety of EUS latex balloon use in patients with a latex allergy.
Salame, Marita; Gleeson, Ferga C; Chandrasekhara, Vinay; Law, Ryan J; Rajan, Elizabeth; Iyer, Prasad G; Bofill-Garcia, Aliana; Ghanem, Omar M; Abu Dayyeh, Barham K; Ravi, Anupama; Storm, Andrew C; Vargas, Eric J.
Afiliación
  • Salame M; Department of Surgery, Mayo Clinic, Rochester, Minnesota, USA.
  • Gleeson FC; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.
  • Chandrasekhara V; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.
  • Law RJ; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.
  • Rajan E; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.
  • Iyer PG; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.
  • Bofill-Garcia A; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.
  • Ghanem OM; Department of Surgery, Mayo Clinic, Rochester, Minnesota, USA.
  • Abu Dayyeh BK; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.
  • Ravi A; Division of Pediatric Allergy and Immunology, Mayo Clinic, Rochester, Minnesota, USA.
  • Storm AC; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.
  • Vargas EJ; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.
Gastrointest Endosc ; 99(6): 1032-1034, 2024 06.
Article en En | MEDLINE | ID: mdl-38280533
ABSTRACT
BACKGROUND AND

AIMS:

Balloons are used in EUS to improve visualization. However, data on the safety of latex balloons in patients with latex allergies are limited, and nonlatex alternatives can be costly. We investigated the safety of latex balloon use during EUS.

METHODS:

A retrospective review was conducted at a tertiary center between 2019 and 2022. Patients with reported latex allergies who underwent linear EUS were included. Baseline demographics, EUS characteristics, and adverse events were collected. The primary outcome was the rate of adverse events.

RESULTS:

Eighty-seven procedures were performed on 57 unique patients (mean age, 65.3 ± 14.5 years). Latex balloons were used in 59 procedures (67.8%), with only 8 procedures (13.6%) using prophylactic medications. No adverse events occurred during or after procedures, regardless of medication use or history of anaphylaxis.

CONCLUSIONS:

The use of EUS latex balloons in patients with a latex allergy was associated with no adverse events.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Endosonografía / Hipersensibilidad al Látex Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2024 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Endosonografía / Hipersensibilidad al Látex Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2024 Tipo del documento: Article